Instituto Bernabeu’s medical codirector and the Reproductive and Genetics Guidance Unit, doctor Andrea Bernabeu, participated last Friday, 15th of January in the digital presentation of the United Kingdom’s Society of Medicine.
Specialized scientific magazine “Reproductive BioMedicine Journal” includes in its December 2020 publication an innovative investigation developed by Instituto Bernabeu’s Genetics department.
Precisely because times are tough, now is the right time to invest. Instituto Bernabeu has decided not to put scientific progress on hold as it waits for better times to come.
Biologists at Instituto Bernabeu Albacete have explained the reproductive medicine clinic’s every dayto the 60 Pharmacy students from the Castilla la Mancha University (UCLM) as part of the clinic’s usual practice.
Rafael Bernabeu Social Fund has maintained its commitment to society in a particularly difficult year where the global pandemic is being devastating.
We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Preimplantational Genetic Diagnosis (PGD) or Preimplantational Genetic Test (PGT)
Grupo Instituto Bernabeu achieves in 2020 a new recognition to its excellency solid policy. The institution has been awarded with the QH** two stars Certificate for the health care quality provided given by the Instituto for the Health Progress and Integration (IDIS in Spanish) and recognises excellence in healthcare organisations that understand quality as part of a culture of continuous improvement. Auditor committee has taken this decision after analysing, checking and validating the proofs sent by Grupo Instituto Bernabeu.
This award values the innovative marketing work, the adaptation capacity, internationalisation and the differentiation between design and communication of the specific pathologies’ treatment.
Instituto Bernabeu’s endocrinologist, Dr Pino Navarro, has taken part of the 9th Ginep Scientific Meeting held in Alicante with the presentation “Pharmacological approach in overweight infertile women.
Instituto Bernabeu’s medical director, doctor Rafael Bernabeu, will address on 12 of November the medical and assistance aspects of the Trans-border Reproductive Medicine.
Instituto Bernabeu’s medical codirector, doctor Joaquin Llacer, low ovarian reserve expert, will participate on November the 5th in the digital experts meeting focused on “Patients with delicate reserve and inadequate response”.
Loyal to the annual meeting, this 2020 Instituto Bernabeu participates in the Miguel Hernandez University (MHU) 16th Pharmacy Students Congress (CEFA in Spanish).
Instituto Bernabeu’s medical codirector, doctor Joaquin Llacer will participate the 3rd of November in an online meeting “Spanish Fertility Society Tuesdays” supported by Gedeon Richter.
In this war against the invisible and relentless enemy, Instituto Bernabeu fights with all possible weapons to keep the highest safety and quality standards in all clinics.
Instituto Bernabeu organises next Thursday November the 5th at 17:00H a free and open to all webinar entitled “Pregnancy medical cares in covid times”. Doctor Francisco Sellers, High Risk Pregnancy Unit director in Instituto Bernabeu, will explain the cares and precautions every pregnant woman must take during pregnancy in current times.
We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". When the family has just one mom and when two moms form a family.
According to the specialists’ Delphy study, coordinated by Instituto Bernabeu and the UMH’s Community and Reproductive Medicine Chair, there’s a unanimous agreement to promote the reproductive planning need from adolescence and in the media
Instituto Bernabeu Medical Director, doctor Rafael Bernabeu, will give this afternoon a master class for the opening of the 9th Master in Reproductive Medicine year 20/21 which has been organized by the University of Alicante (UA) and Instituto Bernabeu.
Instituto Bernabeu organises next Thursday the 29th of October at 17:00H a free webinar to solve all your doubts and offer you advise on the main gynaecological cares and doubts that might require a visit to the specialist doctor.
Instituto Bernabeu Social Fund undertakes for the last 13 years, the egg freeze costs so they may become mothers after overcoming the disease.
The Spanish Fertility Society (SEF in Spanish) has accredited Instituto Bernabeu with a SEF Registry - National Activity Registry participation certificate, this is the Health, Consumer affairs and Social Services Ministry official registry for the assisted reproduction techniques.
Medical coordinator at Instituto Bernabeu, doctor Andrea Bernabeu, has given a lecture about the implications of the vaginal microbiome in pregnancy within the ESHRE Campus. A Forum debate for knowledge exchange in the European Society of Human Reproduction and Embryology, one of the most important worldwide. The meeting held the 1st, 2nd and 3rd of October and under the title “The insuitable uterus” has put the spotlight on the uterus, its diagnosis and study.
Instituto Bernabeu Embryology Unit director, doctor Jorge Ten, offers a virtual lecture aimed towards Chinese Healthcare professionals on September 23rd.
We have launched a new issue of Instituto Bernabeu corporate newsletter "IB Newsletter". Pregnancy and childbirth guarantee programme or 100% reimbursment.
A study carried out by Instituto Bernabeu’s Reproduction Biology, Molecular Biology and Reproductive Medicine and Genetics units, about the embryo biopsy incidence on blastocysts stage (uterus implantation previous phase, around day 5 of embryo development) shows a slight increase of multiple monozygotic pregnancies when using this technique. This study has been published in the Brazilian Society and the Assisted Medicine Latin-American Web along the Brazilian Embryologists Association JBRA scientific magazine.
Dr. Belén Moliner has led new research that was presented at the last congress of the European Fertility Society (ESHRE). The study focused on patients with poor reproductive prognosis, relating progesterone levels to the analysis of uterine contractions on the day of the embryo transfer.
At Instituto Bernabeu we know families have different colours. To ease the way to lesbian, bisexual and transgender couples we have created this Guide which you may download for free.
Instituto Bernabeu has carried out research work that analyses if the vaginal and endometrial microbiome is different in patients who have been diagnosed with recurrent implantation failure (with an uncertain reproduction prognosis). The clinic compared them with women who undergo assisted reproduction treatment but who do not have a diagnosis of this kind.
Journalist Guillermo Arduino has interviewed Dr Rafael Bernabeu on his CNN TV show “Encuentro” to know more about the future of gametogenesis; the experimental in-lab creation of oocytes and sperm as an alternative for infertility issues on those patients who has lost their capability to create their own gametes.
This new research was presented at the last congress of the European Fertility Society that took place on last July. The aim of this study is to identify which embryo features are correlated with higher aneuploidy or mosaicism rates, and if it is possible to predict them.
At Instituto Bernabeu we want to make it easier for women who want to be a mother without a partner. That is why we give away this Guide, which can be downloaded free of charge, to help you in your life project of undertaking motherhood alone.
One of the latest scientific project carried out at Instituto Bernabeu has been accepted at the next European Society for Human Reproduction (ESHRE) congress. The aim of this research was to evaluate the accuracy of niPGT-A by comparing two different chromosome analysis techniques used to study the embryo
In the last meeting of reproductive medicine experts, the European Fertility Congress (ESHRE), we presented a new research developed entirely at Instituto Bernabeu clinics. The study focused on how the technique used for the biopsy prior to an embryonic genetic study (pulling and flicking) affected the genetic results, the rate and type of embryonic mosaicism, as well as the success of PGT-A cycles.
The enzyme methylenetetrahydrofolate reductase (MTHFR) is involved in the metabolism of folic acid which is an essential nutrient for reproduction and pregnancy. There are studies that relate variants in the MTHFR gene with alterations in the embryo and problems with the pregnancy. The variants C677CT and A1298C are the most relevant. The aim of this study, accepted to be presented in a poster at this year's congress of the European Society of Reproduction ESHRE, was to study the relationship of these genetic changes with chromosomal abnormalities in the embryo and with the probability of pregnancy (ongoing pregnancy rate) after the transfer of chromosomally normal embryos
A new research from Instituto Bernabeu associates the state of the patient's cytokines with the diagnosis of low ovarian reserve and response. The conclusions of the work were presented in the last edition of the European Society of Human Reproduction and Embryology (ESHRE) congress, which took place between the 6th and 9th of July.
Instituto Bernabeu and the University of Alicante (UA) will manage the 9th edition of the Master's Course in Reproductive Medicine for the 2020-2021 academic year. The aim is to provide experts from the world of health sciences with excellent and comprehensive training in the field of reproductive medicine.
A new study developed at Instituto Bernabeu has been accepted for presentation at the European Society of Human Reproduction and Embryology (ESHRE) Congress held between the 6th to 8th of July. For this project, 5286 embryos from 1822 cycles between October 2014 and April 2019 were included. The study showed that the segmental alterations were located at the ends (telomeres) of the chromosomes (58.2%).
From the 5th until the 8th of July Instituto Bernabeu presents studies in the field of reproductive biology, molecular biology, genetics and embryology... during this annual meeting.
2020 events conditioned the congress of the European Society of Human Reproduction and Embryology (ESHRE) to be held online for the first time in history. Among different research projects developed at Instituto Bernabeu that its scientific committee has accepted to share with the community, there is a report on the evaluation of the β-hCG pregnancy hormone value as a predictor of the evolution of the pregnancy
Dr. Juan Carlos Castillo will present an Oral Communication at the next ESHRE Meeting of the latest research paper “Natural micronized progesterone versus a GnRH antagonist in egg-donation cycles. An extended experience ”; a new advance to improve medication in egg donors.
The current circumstances have made this scientific event, the most important in the field of Reproductive Medicine, to be held extraordinarily online this year.
Instituto Bernabeu has participated in the creation of the Guide to Practical Care of the Obstetric and Gynecological Ultrasound section of the Spanish Society of Obstetrics and Gynecology.
Optimizes and improves cycles for egg donors, oncology patients, women with low reserve, immature oocyte syndrome and empty follicle syndrome
The international medical journal Upsala Journal of Medical Sciences has just published a research paper led by Instituto Bernabeu entitled "Gonadotropin-releasing hormone agonist ovulation trigger — beyond OHSS prevention". It was developed by Instituto Bernabeu gynecologist, expert in ovarian stimulation, Dr. Juan Carlos Castillo with the participation of Thor Haahr, María Martínez-Moya and Peter Humaidan. The goal of this review is to present the advantages of the gonadotropin-releasing hormone agonist (GnRHa) trigger in ovarian stimulation during reproductive medicine treatment. It highlights that its role goes beyond the prevention of ovarian hyperstimulation syndrome (OHSS).
On Thursday the 21st of May, the doctors of Instituto Bernabeu, Dr. Joaquin Llácer and Dr. Juan Carlos Castillo, have been invited to give a webinar to the doctors of the Peruvian Society of Fertility.
Our Pregnancy and Childbirth Guarantee Program was the first to emerge in Europe, now 6 years ago. It was born with the vocation of providing certainty in success and releasing patients from worries; patients are offered full coverage of all medical assistance they may require in their reproductive treatment until the pregnancy is achieved, eliminating uncertainty until the birth of their child, or they would receive a full reimbursement.
Instituto Bernabeu’s Head Doctor, Dr Rafael Bernabeu, will conduct this Wednesday 29th of April the webinar Covid-19: How and when can I start or retake my fertility treatment? Dr Bernabeu will answer live through YouTube Live, all questions related to this pandemic and how affects fertility treatments from 10am and from 11am to all non-Spanish patients in English.
The new Instituto Bernabeu Group newsletter is now available. 27th OF APRIL Resume the reproductive medicine activity.
The Fertility Image group of the Spanish Fertility Society (SEF) coordinated by Instituto Bernabeu doctor Belén Moliner has organized a webinar for this Wednesday, April 22, to show updates on ultrasound technology.
The difficult situation caused by the Covid-19 pandemic, which affects both men and women in the andrological, gynecological, obstetric and reproductive spheres, is generating a multitude of information, at times confusing, that requires analysis and study to manage it properly.
In these extraordinary times in which we are living, in isolation, we want to be even closer to our patients so they know we remain at their disposal. If you are not yet a patient, but you would like to get to know us, you can also send us your questions.
We know that there are things that cannot wait, and distance and isolation should not be an obstacle. We offer you online fertility consultation, hand in hand with our specialists in the most advanced reproductive medicine. If it is not possible to see each other in person, through personalized attention via videoconference, you can carry out your first fertility appointment online or prepare the next steps of your case if you are already a patient. New technologies bring us closer and help us move forward with our personal goals.
Sometimes, gynecological health requirements or pregnancy needs do not know of confinements and cannot wait, that is why we have especially enabled a few hours to be able to attend to your needs in person. You can carry out gynecological, fertility and pregnancy follow up consultations, as well as diagnostic or laboratory tests that may be required for a correct diagnosis.
Given the seriousness of the situation that our country and its medical professionals are facing to combat the pandemic caused by covid-19, all the clinics of Instituto Bernabeu have given to the health authorities all their medical and surgical equipment that may be necessary to combat coronavirus.
The new Instituto Bernabeu Group newsletter is now available. Coronavirus COVID-19. Uptading regarding our activity status.
Instituto Bernabeu and the role of its genetics and molecular biology laboratory have been used to instruct biotechnology students at Miguel Hernández University (UMH) about the day-to-day demands of their future profession. The talk took place within the framework of the 8th Employment in Biotechnology event, to which the clinic was invited.
Instituto Bernabeu played a leading clinic role in a scientific gathering of assisted reproduction experts organised by Merck in Valencia. Dr Andrea Bernabeu, Co-Director of Instituto Bernabeu and Coordinator of the Genetics and Reproduction Assessment Unit; Dr Jorge Ten, Director of the Embryology Unit; and Dr Juan Carlos Castillo, a gynaecologist and expert in ovarian hyperstimulation syndrome at Instituto Bernabeu, all attended the event.
Ongoing training and participation in congresses is part of the day-to-day work routine at Instituto Bernabeu. One such example this month was the first edition of the Assisted Reproduction Event held in Toledo (Spain) on 21st and 22nd February. Mónica Aparicio, an embryologist at Instituto Bernabeu in Madrid, participated in the gathering of experts where male factor and DNA fragmentation issues were addressed. Her intervention covered the techniques that are performed at the clinic.
At the third edition of the symposium on controversial issues in the field of reproductive and perinatal medicine, Dr Llaneza highlights the role of anti-Müllerian hormone when personalising stimulation
Instituto Bernabeu participated in the third edition of the symposium on controversial issues in the field of reproductive and perinatal medicine which was held in Madrid in late January. Dr Ángela Llaneza, a specialist in reproductive medicine at the clinic in Madrid, participated in the event by giving a lecture entitled ‘Anti-Müllerian Hormone (AMH) and reproduction guidance’.
The Manager of the Embryology Unit at Instituto Bernabeu, Dr Jorge Ten, has given a lecture on the Master’s Course in Human Reproduction organised by Complutense University in Madrid (UCM) and the Spanish Fertility Society (SEF). The doctor has been actively involved in course for over a decade. Dr Ten addressed the issue of oocyte vitrification. Instituto Bernabeu is a groundbreaking clinic in this field with over fifteen years of experience of vitrification of both gametes and embryos. Practices such as these need to be performed under a robust vitrification programme and by experienced embryologists. The Master's Course, in which Instituto Bernabeu plays an active role, trains students in highly specialised reproductive medicine skills and updates their scientific knowledge.
The Instituto Bernabeu Group has obtained the ISO 14001:2015 Environmental Management System Certificate in all its clinics; Alicante, Madrid, Palma de Mallorca, Albacete, Cartagena, Elche and Benidorm.
Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu and expert in poor ovarian reserve; Dr Juan Carlos Castillo, a specialist in ovarian stimulation; and Cristina García-Ajofrín, a gynaecologist at IB in Madrid and an expert in uterine causes of infertility, have given three master classes to students on the University of Alicante and Instituto Bernabeu Master's degree in Reproductive Medicine.
A woman’s ovarian reserve is the number of viable oocytes that she has in her ovaries at any given time. This figure conditions the quantity of ova that can be retrieved during in vitro fertilisation treatment. As a woman ages, her ovarian reserve decreases and this is why the Medical Director at Instituto Bernabeu, Dr Rafael Bernabeu, has emphasised the importance of this factor and encouraged both experts in the field and patients to be keenly aware of this before it is too late.
Instituto Bernabeu participated in a gathering of experts at the ‘Endometriosis and infertility: the extent of the problem’ ESHRE Campus held in Milan on 23rd and 24th January 2020. The scientific event, organised by the European Society of Human Reproduction and Embryology’s endometriosis and endometrial disorders work group, selected research work carried out by Instituto Bernabeu as a candidate for the best poster award. Dr Belén Moliner, the clinic's expert in endometriosis, attended the meeting in order to answer questions about the research work: ‘The inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure with endometriosis and without it.’
Instituto Bernabeu researchers have studied the impact of the male factor on embryo mosaicism or cases of embryos with some normal cells and some chromosomally abnormal cells. It is one of the reasons for implantation failure but the factors that cause it remain unclear. The aim of the study was to assess which male factors could have an impact on embryo mosaicism rates.
The Embryology and Reproductive Medicine Units at Instituto Bernabeu are leading research aimed at determining if a reasonable number of good quality blastocysts (embryos on days 5 to 6 or development prior to implantation) can be retrieved following culture and observation of oocytes that have not fertilised correctly. In in vitro fertilisation laboratories, around 20% of inseminated oocytes suffer fertilisation failure and 3% of oocytes fertilise abnormally.
Instituto Bernabeu has undertaken a research project that aims to analyse if using probiotics could improve pregnancy rates in assisted reproduction treatment. To this end, the clinic has performed a study involving a group of patients with a recurrent implantation failure (RIF) diagnosis, plus another group of patients with no such diagnosis.
Instituto Bernabeu has participated in a professional event for general health and reproductive medicine specialists. The clinic addressed the procedures it adheres to for egg and sperm donation, in addition to means of achieving improved results. The congress was entitled ‘Means of diagnostic and therapeutic healthcare in assisted reproduction procedures and synergies between specialists in the field.’ Instituto Bernabeu addressed the requirements for and access to heterologous artificial insemination through egg donation, sperm donation and embryo adoption.
The genetics laboratory at Instituto Bernabeu is using next-generation sequencing to find out what is behind unknown causes of sterility. In 2020, Instituto Bernabeu will continue with work on the research into this subject that it started in 2018. Instituto Bernabeu points out that next-generation sequencing can be used to work out what causes sterility when other conventional clinical diagnoses techniques cannot.
Instituto Bernabeu research aimed to determine if any ovarian stimulation factors can be linked to oocyte morphology and to the type of membrane breakage when intracytoplasmic spermatozoa injection (ICSI) is performed. This assisted reproduction technique is routinely used in in vitro fertilisation (IVF) laboratories. It has the huge advantage of providing a helping hand when male patients suffer from severe male factors and it stops sperm counts from being a limitation. However, the main disadvantage is that the results depend to a large degree on the operator performing the technique. Although specialists are currently able to perform the process securely, there are some variations in the results that they obtain. Differences between oocytes in ICSI are observed even when an egg donation programme is used.
The new Instituto Bernabeu Group newsletter is now available. Microbiome analysis in patients with embryo implantation failure.
Instituto Bernabeu in Cartagena is organising a scientific event to address progress in the treatment of uterine fibroids. The event will be held on Friday, 31st January in the graduation room at the Polytechnic University in Cartagena. This is just one of many scientific events that the clinic regularly organises at its Cartagena branch. The purpose of the events is to improve knowledge of reproductive health.
Instituto Bernabeu is set to employ a new technique that helps women under 35 years of age to have children with their own ova. These women are otherwise compelled to turn to egg donation
Instituto Bernabeu's social welfare entity invests over €123,000 in courses of treatment for patients who have limited financial resources. This is over 70% of the €176,000 total spend. It donates €33,500 to NGOs, €14,200 to science and research and €10,000 to student scholarships.
Instituto Bernabeu’s participation in events held in Portugal on 4th and 5th December focused on poor responders and new strategies to help women achieve a pregnancy.
Does the number of oocytes obtained following ovarian puncture have an impact on embryo quality? This is the question that a team of researchers from the Embryology Departments at Instituto Bernabeu in Alicante and Albacete and the genetics laboratory at Biotech asked themselves as they proceeded to study the results obtained in almost 400 cycles of in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI). The research work was presented in poster format at the Association for the Study of Reproduction Biology (ASEBIR) Congress, a gathering attended by leading global experts. The research was based on the relationship between the number of oocytes obtained following ovarian puncture and the results of IVF treatment.
Dr Rafael Bernabeu, Medical Director at Instituto Bernabeu, gave a speech within the framework of the ‘Review and updated handling of recurrent pregnancy loss’ course held in Madrid. The event was organised by the Spanish Society of Gynaecology and Obstetrics (SEGO).
A team of researchers from the Embryology and Reproductive Medicine Units at Instituto Bernabeu in Madrid and Alicante have completed a study of the factors that may have the greatest impact on embryo transfer rates following a cycle of assisted reproduction. The research work was presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in late October in Cáceres.
The aim of research work performed by the Genetics and Molecular Biology Department at Instituto Bernabeu IBBiotech was to determine if there is a relationship between the ovarian stimulation process in cycles of in vitro fertilisation (IVF) and the aneuploidy and mosaicism rate in embryos. The conclusions were presented at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in October in Cáceres.
Instituto Bernabeu gave an oral communication about oocyte vitrification at the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres in October. Freezing is common practice during in vitro fertilisation (IVF) treatment because it increases the available number of blastocysts for analysis.
Instituto Bernabeu’s strive for excellence is clearly marked out in a meticulous work method and implementation of the most demanding healthcare and process quality controls with the aim of always achieving excellent results. The healthcare that patients are given is endorsed by certifications and accreditations awarded to the clinic by independent entities. Instituto Bernabeu Group has recently been awarded the QH* accreditation. It entails not only a renewal of the Quality Healthcare (QH) certification, but also an additional, higher level that has been driven by the ‘increase in the validity of certain certifications’, as highlighted by the Institute for Development and Integration of Health (IDIS), the accrediting organism.
Instituto Bernabeu gave an oral communication at the European Society of Human Reproduction and Embryology (ESHRE) Congress entitled ‘The luteal phase of double ovarian stimulation treatment (DuoStim) provides higher oocyte and blastocyst yield in unselected infertile patients: a retrospective, same-patient, cohort study.’ This study is included in the articles that Merck has featured in its specialist journal focussing on fitting publications that is released following the scientific gathering focussing on fitting publications.
Instituto Bernabeu attended the Association for the Study of Reproduction Biology (ASEBIR) Congress held in Cáceres and presented a study about the effect that segmental chromosomal aneuploidies have on the embryo.
Once again this year, Instituto Bernabeu attended the Association for the Study of Reproduction Biology (ASEBIR) Congress. It was held in Cáceres from 23rd to 25th October 2019. Nine items of research work performed by the Embryology Unit and the Molecular Biology and Genetics Department were presented at the national congress. It is the most significant congress of its kind in the field of reproduction biology.
Instituto Bernabeu attended the World of Microbiome Pregnancy, Birth and Infancy congress held in Milan, Italy from 31st October to 2nd November. Dr Belén Lledó, Scientific Director of IBBiotech presented Instituto Bernabeu’s pioneering research into the impact of the vaginal microbiome on the results of assisted reproduction treatment.
Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, moderated the Endometrial Receptivity Workshop held within the framework of the 4th Clinical Workshops on Reproduction Medicine organised by Ferring and held in Valencia on 8th and 9th November.
Instituto Bernabeu has submitted a pilot study involving ova donors to the European Society of Human Reproduction and Embryology (ESHRE). It researches differences in results when conventional ovarian stimulation protocols are applied in comparison with new, no fixed time stimulation protocols that do not take the stage of the menstrual cycle into account. The research entailed an analysis of ova donation cycles which was performed over ten months. It compared stimulation beginning on days 1 to 3 with ovarian stimulation that had no fixed time from day 4 onwards.
The Rafael Bernabeu Social Welfare Foundation has published the results of the 2018-2019 scholarships awards. The scholarships provide Medicine, Nursing, Biology and Biotechnology students in Spain with financial support in order boost their studies. On this occasion, further to assessment of all the applications that were received, the Awards Committee chose to award four students the scholarships worth a total of 10,000 euros.
Instituto Bernabeu participated in the 75th edition of the American Society for Reproductive Medicine (ASRM) congress held from 12th to 16th October in Philadelphia. It is one of the leading congresses in the world both in terms of the number of participants and in terms of the quality of the work that is presented there. Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, was the clinic representative at the global gathering of experts attended by 9,300 people from 94 countries. It is a not-to-be-missed event in the field.
The recent international congress Meeting The Experts provided relevant reviews and information on the latest scientific advances in the treatment of reproductive problems. We were able to interview all the speakers that clarified these aspects. Here are all the videos of the interviews to broaden and complete their contribution.
Dr Rafael Bernabeu, Medical Director of Instituto Bernabeu, has addressed medical and healthcare aspects of cross-border reproductive medicine in a gathering of experts in law organised by the University of Alicante (UA). The seminar, entitled ‘Multi-disciplinary outlooks for studying healthcare in cross-border reproduction’, was held on 23rd September and gynaecologist Dr Bernabeu delivered the specialist’s point of view on the subject. The event was organised by the Department of Civil Law and it was attended by full professors and associate professors in Sociology and Civil Law.
Pharmacogenetics and Genomics, a specialist journal, recently published Instituto Bernabeu research work into ovarian reserve and pharmacogenetics, a subject in which the clinic is a leading entity and pioneer. The research was managed by Dr Belén Lledó, Scientific Director of Instituto Bernabeu Biotech, and it addressed the relevance of individual screening of the genetic variants in terms of ovarian response prediction. The aim was to determine if the polymorphisms in some genes involved in ovarian follicle maturation can predict ovarian response.
The Journal of Assisted Reproduction and Genetics (JARG) has cited the conclusions that were reached during the research
Instituto Bernabeu has brought the third edition of the international Meeting the Experts event for specialists in the field of reproductive medicine (27th and 28th September) to a close. The event was held in the Alicante facilities and 140 experts including gynaecologists, geneticists, biologists, molecular biologists, pharmacists and artificial intelligence specialists from China, USA, Australia, Israel, Belgium, Norway, Denmark, England, Italy and Switzerland met there to exchange knowledge and experiences.
Dr Joaquín Llácer, Medical Co-Director of Instituto Bernabeu, participated in Next Now Theramex Fertility held in Valencia on 20th and 21st September. International experts in the field attended the professional event. Dr Llácer, who is a gynaecologist, addressed the impact of genetic polymorphisms on ovarian response. Poor ovarian reserve is one of the most common issues in the field of reproductive medicine and Dr Llácer is a renowned specialist in this area. He manages the department dedicated to this issue at Instituto Bernabeu.
Instituto Bernabeu has submitted research work about optimisation of ovarian stimulation in oocyte donation cycles to the European Society of Human Reproduction and Embryology (ESHRE). The research involves using oral progesterone instead of the GnRH antagonist, the alternative pharmaceutical drug that has traditionally been used to control when ovulation takes place. The main advantage of this strategy is how easy it is for patients because it entails fewer injections.
Dr Jorge Ten, Manager of the Embryology Unit at Instituto Bernabeu, will participate today, Tuesday 17th September, in a CooperSurgical workshop held in Valencia and entitled ‘Experiences using LifeGlobal Total LP (5mg) Culture Media’. The event on embryo culture brings together embryology managers so that they can present their experience and most recent results with this embryo culture and transfer medium.
The August 2019 issue of the Journal of Assisted Reproduction and Genetics (JARG) referenced research work about abnormal sperm analysis using the FISH (fluorescence in situ hybridisation) diagnosis technique and in which Instituto Bernabeu is participating. This specialist journal, which is published by the American Society of Reproductive Medicine (ASRM), accepted the research on the use of FISH in assisted reproduction techniques which involves analysis of part of the chromosomal make-up of spermatozoa.
Instituto Bernabeu has submitted research work to the European Society of Human Reproduction and Embryology (ESHRE), the leading worldwide entity in the field of reproductive medicine. The purpose of the research was to understand if using Embryoglue® as the culture medium for embryo transfer to the mother's uterus improves results.
Instituto Bernabeu is unrelenting in its research work and its trials are featured in leading congresses in the field of reproductive medicine.
Instituto Bernabeu’s seventh reproductive medicine clinic has opened in Palma de Mallorca. It is located in Avenida de Aragón, number 8, right in the commercial heart of Mallorca, opposite El Corte Inglés. The clinic specialises in personalised solutions and courses of fertility treatment that have been designed to suit each patient. Its branch in Mallorca uses the very latest developments in the field of genetics and reproductive medicine. Its treatment units, such as the Poor Ovarian Reserve Unit and Embryo Implantation Failure Unit are internationally renowned.
For a further year, the European Society of Human Reproduction and Embryology (ESHRE) has summoned a broad group of specialists from Instituto Bernabeu to take part in their scientific round table discussions and debate groups concerning infertility at the largest reproductive medicine and embryology scientific conference held in 2019. Our clinic experts, who contributed their own scientific papers, have thus collaborated in the development of reproductive medicine for a further year.
The new Instituto Bernabeu Group newsletter is now available. Thanks to a flawless technical test and a highly regarded report, our embryo PGT-A (pre implantation genetic test) screening was awarded the top score.
Instituto Bernabeu and the University of Alicante (UA) will manage the 8th edition of the Master's Course in Reproductive Medicine for the 2019-2020 academic year. The aim is to provide experts from the world of health sciences with excellent and comprehensive training in the field of reproductive medicine.
Students from the 7th Reproductive Medicine Master's Degree by University of Alicante (UA) and Instituto Bernabeu have concluded their 2018/2019 course with a closing ceremony held at the clinic's premises.
Next September 2019 will see a number of renowned, worldwide experts in the different reproductive medicine areas meet at Instituto Bernabeu's III International Meeting the Experts conference. This triennial event is aimed at sharing new fertility related developments and knowledge with the purpose of attaining a renewed approach concerning the most important challenges facing reproductive medicine.
Instituto Bernabeu undertakes vital healthcare work which is supplemented by its participation in congresses and both national and international events. One of this month's most relevant event took place in Cordoba. The 7th SEF National Meeting of Groups of Interest was held on 7th and 8th June. Every two years, the Spanish Fertility Society brings together experts in assisted reproductive medicine in order to share updated ideas and make new contributions across various fields.
The genetics laboratory at Instituto Bernabeu has been awarded the highest possible mark in an assessment of its PGT-A genetics test by an external and independent European organism. The assessment was performed anonymously on 56 European laboratories. The PGT-A test assesses if the embryo is chromosomally normal or aneuploidy. It is recommended for women who are older when having children; women who have a background of recurrent pregnancy loss; and women who have suffered from implantation failure. This test is also recommended for couples who have chromosomal abnormalities.
Leading experts worldwide in the field of infertility will gather in Vienna in June. The event is unmissable for Instituto Bernabeu since the clinic will play an active role and will make research work developed by the clinic public.
The new Instituto Bernabeu Group newsletter is now available. Our group will be actively present at the 35th edition of ESHRE in June. The scientific committee has accepted 9 clinical studies borne of the team of human resources at Instituto Bernabeu based on our research work that focuses on poor ovarian reserve and embryo implantation failure.
Dr Jorge Ten, Director of the Embryology Unit, participated in a gathering of specialists who debated the main trends in terms of techniques and protocols for treating patients who have a difficult prognosis.
The next 27th and 28th September will take place the 3rd Edition of "Meeting the Experts", the international reproductive medicine conference organized by Instituto Bernabeu.
Instituto Bernabeu has participated in the first edition of the Master's Course in Primary Healthcare at the University Of Castilla La Mancha (UCLM) with an intervention on latest developments in the field of reproductive medicine. The specialist training course is aimed at general practitioners, resident doctors and nursing students and its objectives include increasing participants’ capacity to resolve most of the problems presented by patients who request appointments with their general practitioner, the most proximate level of healthcare. The Master's Course includes updates on the latest developments in terms of diagnosis and treatment in primary healthcare. It is for this reason that gynaecology and reproductive medicine play a significant role.
Leyre Herrero, our Head of Human Biology laboratory in Instituto Bernabeu Madrid, will lead a practical theoretical workshop this Thursday where the protocol Kitazato on vitrification and devitrification will be addressed. The training session will take place in Marbella at the HC International Hospital.
Instituto Bernabeu has been included as a Quality Clinic on the Autonomous Community of Valencia Official Register of Health Clinics. This means that the clinic has been included on the Autonomous Community of Valencia Register of Quality Certifications for Health Clinics, Services and Establishments. It covers, on the one hand, the ISO 9001:2015 certification that the clinic was awarded in January 2016 for ‘Provision of assisted reproduction clinic healthcare, gynaecology consultations and pregnancy control. Performing molecular biology, andrology laboratory, semen bank, oocyte bank and embryo bank activities.’ On the other, the Autonomous Community Register has added UNE-EN 179006:2013 for ‘Management of patient safety risks’, awarded in December 2015.
Research that was carried out by the Genetics Unit at Instituto Bernabeu Biotech and entitled ‘Mosaic segmental aneuploidies in trophectoderm cells do not affect pregnancy rates in cycles of in vitro fertilisation (IVF)’ has been selected as one of the best oral presentations at the 2nd Human Genetics Interdisciplinary Congress held in Madrid between 3rd and 5th April 2019.
Instituto Bernabeu presents research work on the impact of mitochondrial DNA when predicting an embryo's ability to implant at the 18th Congress of the Pre-implantation Genetic Diagnosis International Society
The Genetics Department at Instituto Bernabeu was present at the 18th International Conference on pre-implantation genetics organised by the Pre-implantation Genetic Diagnosis International Society (PGDIS) and held in Geneva (Switzerland) between 15th and 18th April. Leading experts in reproductive biology, genetics and embryology met at the event which addressed development of pre-implantation genetic testing (PGT) technology.
Medical Co-Director of Instituto Bernabeu, Dr Joaquín Llácer, and Dr Paolo Cirillo participated in the 2nd National Congress of the Reproductive Medicine Foundation of Italy (PMA) held in Florence on 21st and 22nd March. Dr Llácer, an expert in poor ovarian reserve, gave a conference delivered to specialists in assisted reproduction that addressed the ‘Challenges of treating patients with poor ovarian response.’